Efficacy and Safety of High-Density Lipoprotein/Apolipoprotein A1 Replacement Therapy in Humans and Mice With Atherosclerosis: A Systematic Review and Meta-Analysis

Background: Although elevation of HDL-C levels by pharmaceutical drugs have no benefit of cardiovascular endpoint, the effect of high-density lipoprotein/apolipoprotein A1 (HDL/apoA-1) replacement therapy on atherosclerosis is controversial. The current meta-analysis analyzed the effects of HDL/apoA...

Descripción completa

Detalles Bibliográficos
Autores principales: Abudukeremu, Ayiguli, Huang, Canxia, Li, Hongwei, Sun, Runlu, Liu, Xiao, Wu, Xiaoying, Xie, Xiangkun, Huang, Jingjing, Zhang, Jie, Bao, Jinlan, Zhang, Yuling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377725/
https://www.ncbi.nlm.nih.gov/pubmed/34422927
http://dx.doi.org/10.3389/fcvm.2021.700233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377725/
https://www.ncbi.nlm.nih.gov/pubmed/34422927
http://dx.doi.org/10.3389/fcvm.2021.700233

Ejemplares similares